33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 1.5 H,Reflux 标题:Treatment Of Cancers Having K-Ras Mutations Using Pi3 Kinase And Hdac Inhibitors And Preparation Of Bifunctional Thienopyrimidine Compounds That Inhibit Both Enzymes 参考文献:World Intellectual Property Organization]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; Rt -> Reflux; 1.5 H,Reflux 标题:Preparation Of Tetrahydroindazoles As Hsp90 Inhibitors Containing A Zinc Binding Moiety 参考文献:World Intellectual Property Organization]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 1.5 H,Rt -> Reflux 标题:Preparation Of Oxazolylmethylthio Thiazoles As Cdk Inhibitors Containing A Zinc Binding Moiety 参考文献:World Intellectual Property Organization]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Acetic Acid,Bromine; 2 H,Reflux 标题:Thieno[3,2-D]Pyrimidine Derivs In Combination Therapy As A Phosphoinositide 3-Kinase Inhibitor With A Zinc Binding Moiety And Their Preparation 参考文献:World Intellectual Property Organization]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 1.5 H,Reflux 标题:Deazapurines,Thienopyrimidines And Furopyrimidines As Phosphoinositide 3-Kinase Inhibitors With A Zinc Binding Moiety And Their Preparation And Use In The Treatment Of Diseases 参考文献:United States]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 1.5 H,Rt -> Reflux 标题:Isoxazole Derivatives As Hsp90 Inhibitors,Their Preparation,Pharmaceutical Compositions,And Use In The Treatment Of Cell Proliferative Diseases 参考文献:World Intellectual Property Organization]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 2 H,Reflux 标题:Preparation Of Thienopyrimidine Derivatives And Their Use In Combination Therapy With A Phosphoinositide 3-Kinase Inhibitor With A Zinc Binding Moiety 参考文献:United States]
33458-27-4 = 95928-49-7 反应条件:1.1 Reagents: Bromine Solvents: Acetic Acid; 3 H,110 °C; < 110 °C; 12 H,Rt 标题:Design And Synthesis Of Novel Androgen Receptor Antagonists Via Molecular Modeling 作者:Zhao,Chao; Choi,You Hee; Khadka,Daulat Bikram; Jin,Yifeng; Lee,Kwang-Youl; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2016 卷标:24(4) 页码:789-801]
= 95928-49-7 [标题:Reaction Conditions 标题:Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase 参考文献:United States
📜Ethyl 2-Oxo-1,2,3,4-Tetrahydropyrimidine-5-Carboxylate置于溴,溶剂黄146体系中,化学反应 1.5H,以3.6 G的收率获得产物2-羟基嘧啶-5-羧酸乙酯 参考文献:Treatment Of Cancers Having K-Ras Mutations 标题:Treatment Of Cancers Having K-Ras Mutations 摘要:本发明提供了一种治疗与k-Ras突变相关的癌症的方法,适用于需要该方法的受试者.该方法包括以下步骤:(1)识别患有与k-Ras突变相关的癌症的受试者;和(2)向受试者施用(i)pi3激酶抑制剂和(II)hdac抑制剂,其中pi3激酶抑制剂和hdac抑制剂以联合治疗有效的剂量进行施用.
专利号:US-2011152295-A1 优先权日:2008-09-08 标 题:Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase 发明人:LECLERC JEAN-PHILIPPE; LI CHUN SING; RAMTOHUL YEEMAN K 权利人:LECLERC JEAN-PHILIPPE; LI CHUN SING; RAMTOHUL YEEMAN K 摘要:Heteroaromatic compounds of structural formula I are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.
参考文献:10.1007/s13738-012-0097-0 摘要:Memarian HR, Soleymani M, Sabzyan H. Light-induced dehydrogenation of 2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamides. Journal of the Iranian Chemical Society. 2012 May 04;9(5):805–13. doi: 10.1007/s13738-012-0097-0. 参考文献:10.1134/s1070363217040284 摘要:Gorjizadeh M, Afshari M. 4-Bis(triphenylphosphonium)-2-butene peroxodisulfate as an efficient oxidizing agent for one-pot synthesis of ethyl pyrimidin-2(1H)-one-5-carboxylates. Russian Journal of General Chemistry. 2017 Apr;87(4):842–5. doi: 10.1134/s1070363217040284. 参考文献:10.1007/bf03246543 摘要:Memarian HR, Farhadi A. Potassium peroxydisulfate as an efficient oxidizing agent for conversion of ethyl 3,4-dihydropyrimidin-2(1H)-one-5-carboxylates to their corresponding ethyl pyrimidin-2(1H)-one-5-carboxylates. Journal of the Iranian Chemical Society. 2009 Sep;6(3):638–46. doi: 10.1007/bf03246543.